Does TOCILIZUMAB Cause Haemoglobin decreased? 708 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 708 reports of Haemoglobin decreased have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.7% of all adverse event reports for TOCILIZUMAB.
708
Reports of Haemoglobin decreased with TOCILIZUMAB
0.7%
of all TOCILIZUMAB reports
99
Deaths
407
Hospitalizations
How Dangerous Is Haemoglobin decreased From TOCILIZUMAB?
Of the 708 reports, 99 (14.0%) resulted in death, 407 (57.5%) required hospitalization, and 142 (20.1%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 708 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which TOCILIZUMAB Alternatives Have Lower Haemoglobin decreased Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE